IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i10p6110-d817776.html
   My bibliography  Save this article

Lessons We Have Learned Regarding Seroprevalence in High and Low SARS-CoV-2 Contexts in Greece before the Omicron Pandemic Wave

Author

Listed:
  • Ourania S. Kotsiou

    (Faculty of Nursing, School of Health Sciences, University of Thessaly, GAIOPOLIS, 41110 Larissa, Greece
    Department of Respiratory Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, BIOPOLIS, 41110 Larissa, Greece
    These authors contributed equally to this work.)

  • George D. Vavougios

    (Department of Respiratory Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, BIOPOLIS, 41110 Larissa, Greece
    These authors contributed equally to this work.)

  • Dimitrios Papagiannis

    (Public Health & Vaccines Lab, Department of Nursing, School of Health Sciences, University of Thessaly, GAIOPOLIS, 41110 Larissa, Greece)

  • Elena Matsiatsiou

    (Faculty of Nursing, School of Health Sciences, University of Thessaly, GAIOPOLIS, 41110 Larissa, Greece)

  • Dimitra Avgeri

    (Faculty of Nursing, School of Health Sciences, University of Thessaly, GAIOPOLIS, 41110 Larissa, Greece)

  • Evangelos C. Fradelos

    (Faculty of Nursing, School of Health Sciences, University of Thessaly, GAIOPOLIS, 41110 Larissa, Greece)

  • Dimitra I. Siachpazidou

    (Department of Respiratory Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, BIOPOLIS, 41110 Larissa, Greece)

  • Garifallia Perlepe

    (Department of Respiratory Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, BIOPOLIS, 41110 Larissa, Greece)

  • Angeliki Miziou

    (Department of Respiratory Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, BIOPOLIS, 41110 Larissa, Greece)

  • Athanasios Kyritsis

    (Department of Respiratory Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, BIOPOLIS, 41110 Larissa, Greece)

  • Eudoxia Gogou

    (Department of Respiratory Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, BIOPOLIS, 41110 Larissa, Greece)

  • Serafim Kalampokas

    (School of Health Sciences, University of Thessaly, GAIOPOLIS, 41110 Larissa, Greece)

  • Georgios Kalantzis

    (Department of Respiratory Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, BIOPOLIS, 41110 Larissa, Greece)

  • Vaios S. Kotsios

    (Metsovion Interdisciplinary Research Center, National Technical University of Athens, 44200 Athens, Greece)

  • Konstantinos I. Gourgoulianis

    (Department of Respiratory Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, BIOPOLIS, 41110 Larissa, Greece)

Abstract

Background: Antibody seroprevalence in rural communities remains poorly investigated. We compared the SARS-CoV-2 seroprevalence in two Greek communities in June and July 2021 after the end of the Delta-driven pandemic wave that started in November 2020. One community was affected worse than the other. Methods: The SARS-CoV-2 IgG II Quant method (Architect, Abbott, IL, USA) was used for antibody testing. Results: We found a high rate of SARS-CoV-2 seropositivity in both communities, approaching 77.5%. In the area with a higher burden of COVID-19, Malesina, seropositivity was achieved with vaccine-acquired and naturally acquired immunity, whereas in the low-burden context of Domokos, the high rates of seropositivity were achieved mainly with vaccination. Previously infected individuals were less likely to be vaccinated than previously uninfected adults. The antibody titers were significantly higher in previously infected, vaccinated participants than in unvaccinated ones. In total, 4% and 10% of the unvaccinated population were diagnosed seropositive for the first time while not knowing about the previous infection. Age and gender did not impact antibody titers in high- or low-burden contexts. Conclusions: Before the Omicron pandemic wave, herd immunity was reached in different contexts in Greece. Higher antibody titers were measured in infected vaccinated individuals than in infected unvaccinated ones.

Suggested Citation

  • Ourania S. Kotsiou & George D. Vavougios & Dimitrios Papagiannis & Elena Matsiatsiou & Dimitra Avgeri & Evangelos C. Fradelos & Dimitra I. Siachpazidou & Garifallia Perlepe & Angeliki Miziou & Athanas, 2022. "Lessons We Have Learned Regarding Seroprevalence in High and Low SARS-CoV-2 Contexts in Greece before the Omicron Pandemic Wave," IJERPH, MDPI, vol. 19(10), pages 1-8, May.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:10:p:6110-:d:817776
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/10/6110/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/10/6110/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. N. Ahmad Aziz & Victor M. Corman & Antje K. C. Echterhoff & Marcel A. Müller & Anja Richter & Antonio Schmandke & Marie Luisa Schmidt & Thomas H. Schmidt & Folgerdiena M. Vries & Christian Drosten & M, 2021. "Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany," Nature Communications, Nature, vol. 12(1), pages 1-10, December.
    2. Timokleia Kousi & Lefkothea-Christina Mitsi & Jean Simos, 2021. "The Early Stage of COVID-19 Outbreak in Greece: A Review of the National Response and the Socioeconomic Impact," IJERPH, MDPI, vol. 18(1), pages 1-17, January.
    3. Ourania S. Kotsiou & Dimitrios Papagiannis & Evangelos C. Fradelos & Dimitra I. Siachpazidou & Garifallia Perlepe & Angeliki Miziou & Athanasios Kyritsis & George D. Vavougios & Georgios Kalantzis & K, 2021. "Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community," IJERPH, MDPI, vol. 19(1), pages 1-8, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Rastko Jovanović & Miloš Davidović & Ivan Lazović & Maja Jovanović & Milena Jovašević-Stojanović, 2021. "Modelling Voluntary General Population Vaccination Strategies during COVID-19 Outbreak: Influence of Disease Prevalence," IJERPH, MDPI, vol. 18(12), pages 1-18, June.
    2. Felix Dewald & Martin Pirkl & Martha Paluschinski & Joachim Kühn & Carina Elsner & Bianca Schulte & Jacqueline Knüfer & Elvin Ahmadov & Maike Schlotz & Göksu Oral & Michael Bernhard & Mark Michael & M, 2023. "Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    3. Lei Jiang & Yujia Huang & Haonan Cheng & Ting Zhang & Lei Huang, 2021. "Emergency Response and Risk Communication Effects of Local Media during COVID-19 Pandemic in China: A Study Based on a Social Media Network," IJERPH, MDPI, vol. 18(20), pages 1-16, October.
    4. Johannes Korth & Benjamin Wilde & Sebastian Dolff & Jasmin Frisch & Michael Jahn & Adalbert Krawczyk & Mirko Trilling & Leonie Schipper & Sebastian Cordes & Birgit Ross & Monika Lindemann & Andreas Kr, 2021. "SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study," IJERPH, MDPI, vol. 18(9), pages 1-10, April.
    5. Uxue Alfonso Viguria & Núria Casamitjana, 2021. "Early Interventions and Impact of COVID-19 in Spain," IJERPH, MDPI, vol. 18(8), pages 1-15, April.
    6. Georgios Lazaridis & Dimitris Panaretos & Antonia Matalas, 2022. "The Impact of the COVID-19 Pandemic on the Food-Related Behaviour of Tourists Visiting Greece," Tourism and Hospitality, MDPI, vol. 3(4), pages 1-22, September.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:10:p:6110-:d:817776. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.